This is the authors' abstract. We don't add key points for this paper.
mFOLFOX6-based preoperative chemoradiotherapy results in a higher pCR rate than fluorouracil-based treatment. Perioperative mFOLFOX6 alone had inferior results and a lower pCR rate than chemoradiotherapy but led to a similar downstaging rate as fluorouracil-radiotherapy, with less toxicity and fewer postoperative complications.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: